NEONC TECHNOLOGIES HOLDINGS, INC. Labor and Related Expense
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Labor and Related Expense of $268.80 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LaborAndRelatedExpense · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. labor and related expense for the quarter ending 2026-06-30 was $268.80K, a 64.01% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. labor and related expense for the quarter ending 2026-03-31 was $189.23K, a 17.17% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. labor and related expense for the quarter ending 2025-12-31 was $170.07K, a 51.99% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. labor and related expense for the quarter ending 2025-09-30 was $182.27K, a 2.08% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. labor and related expense for fiscal 2025 was $686.50K, a 0.05% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. labor and related expense for fiscal 2024 was $686.13K.
| Period end | Labor and Related Expense 3 month | Labor and Related Expense 6 month | Labor and Related Expense 9 month | Labor and Related Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $268.80K 10-Q · filed 2026-08-10 | $458.02K 10-Q · filed 2026-08-10 | $628.10K derived: sum of 3 quarters · filed 2026-08-10 | $810.36K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $189.23K 10-Q · filed 2026-05-15 | $359.30K derived: sum of 2 quarters · filed 2026-05-15 | $541.57K derived: sum of 3 quarters · filed 2026-05-15 | $705.45K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $170.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $352.34K derived: sum of 2 quarters · filed 2026-03-31 | $516.23K derived: sum of 3 quarters · filed 2026-08-10 | $686.50K 10-K · filed 2026-03-31 |
| 2025-09-30 | $182.27K 10-Q · filed 2025-11-14 | $346.15K derived: sum of 2 quarters · filed 2026-08-10 | $516.43K 10-Q · filed 2025-11-14 | $861.91K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $163.89K 10-Q · filed 2026-08-10 | $334.16K 10-Q · filed 2026-08-10 | $679.64K derived: sum of 3 quarters · filed 2026-08-10 | $865.79K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $161.49K 10-Q · filed 2026-05-15 | $515.75K derived: sum of 2 quarters · filed 2026-05-15 | $701.90K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $354.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $540.41K derived: sum of 2 quarters · filed 2026-03-31 | $686.13K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $186.15K 10-Q · filed 2025-11-14 | $331.87K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $145.72K 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |